What Do You Remember From SABCS?
Do you remember the research presented at SABCS 2024? Test your knowledge now and see how you rank!
Read More
Author: Rebecca Shover
Addressing Individual Clinicians’ Needs Improves Management of Tardive Dyskinesia
A short educational activity on tardive dyskinesia significantly improved clinicians’ confidence in managing and choosing therapies.
Read More
Quiz Challenge – How Do You Treat These Menstrual Disorders?
From polycystic ovarian syndrome to endometriosis, how well do you know the diagnosis and...
Read More
Are You Attending the 2025 Winter Clinical Meeting?
The upcoming 2025 Winter Clinical meeting, taking place in Hawaii, will showcase insights from specialists in psoriasis, hidradenitis suppurativa, and more.
Read More
Curbing Costs & Burden: Comparing Phototherapy Options for Patients With Psoriasis
Research published in JAMA Dermatology indicated that home-based phototherapy was as effective as office-based phototherapy for patients with psoriasis.
Read More
VISIBLE Trial Addresses Knowledge Gaps in Psoriasis in Skin of Color
Findings from the VISIBLE trial will help address gaps in psoriasis care for patients with skin of color and inform best practices to drive inclusive research.
Read More
CLL/SLL: Treatment Updates, Improving QOL, and More
A curated roundup of what happened at ASH 2024, focused on CLL/SLL – treatment updates, improving QOL, and novel agents.
Read More
Finding Strength in Connection
Just as physicians seek help for others, they should also seek support in overcoming challenges in their personal lives, as there is strength in connection.
Read More
Quiz Challenge – Think You Know STI Management?
A 32-year-old pregnant woman (G2P1) presents for routine prenatal screening. She is asymptomatic, but laboratory testing reveals a positive syphilis serology.
Read More
The Impact of Extreme Temperatures on COPD Morbidity and Mortality
Extreme temperatures increase COPD hospitalizations and deaths, with cold having a greater impact.
Read More
Navigating the Treatment Landscape for ROS1+ NSCLC
Physician’s Weekly spoke with Luis Raez, MD, to learn more about an FDA-approved targeted therapy option for patients with advanced ROS1+ NSCLC.
Read More
Tailoring ROS1+ NSCLC Treatment: The Role of Biomarker Testing
Physician’s Weekly spoke with Debora Bruno, MD, to explore how biomarker testing may guide treatment decisions for patients with advanced ROS1+ NSCLC.
Read More
The Role of the Multidisciplinary Team for ROS1+ NSCLC
Physician’s Weekly spoke with Edgardo Santos, MD, about the multidisciplinary team’s role in developing treatment plans for patients with advanced ROS1+ NSCLC.
Read More
Identifying Effective Treatment Options for TD & Their Safety Profiles
Valbenazine and vitamin E are the most effective treatments for tardive dyskinesia, with valbenazine showing the strongest effect size in recent studies.
Read More
The Role of Pharmacists in Oncology Care
Physician’s Weekly spoke with Whitney Lewis, PharmD, about the evolving role of pharmacists in managing NSCLC.
Read More
The Latest Insights on Preeclampsia Assessment
Recent preeclampsia studies have investigated predictors such as placenta location and PAPP-A, in addition to comparing the P/C ratio with 24-hour proteinuria.
Read More
The Gut-Brain Connection: Fibromyalgia Management Insights
A study exploring the link between disorders of gut-brain interaction and fibromyalgia severity offers insights into managing this complex condition.
Read More
Impact of Second Primary Malignancies on Survival in Patients With MCL
MCL patients with secondary malignancies have significantly shorter survival, particularly due to skin cancers and secondary leukemia.
Read More
Exploring COVID-19 Vaccination & Infection in Patients With MM
The ASH Research Collaborative developed the COSMIC study to address the risks severe COVID-19 complications pose to patients with multiple myeloma.
Read More
Bridging Technology and Personalized Care in Psoriasis Management
The TELEPROM Psoriasis study highlights how telepharmacy and patient-reported outcomes improve the quality of life for patients with moderate-to-severe psoriasis.
Read More